-
EP4313037
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4313037
| EP4313037 - PHARMACEUTICAL COMPOSITIONS COMPRISING ZOLMITRIPTAN [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.01.2024 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 30.09.2022 | Most recent event Tooltip | 31.05.2024 | Change: Validation states | published on 03.07.2024 [2024/27] | 31.05.2024 | Change - extension states | published on 03.07.2024 [2024/27] | Applicant(s) | For all designated states MapLight Therapeutics, Inc. 501 2nd Street San Francisco, CA 94107 / US | [2024/06] | Inventor(s) | 01 /
WOOD, Michael San Francisco, California 94107 / US | 02 /
LILLIE, James San Francisco, California 94107 / US | [2024/06] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [2024/06] | Application number, filing date | 22776651.6 | 24.03.2022 | [2024/06] | WO2022US21738 | Priority number, date | US202163165938P | 25.03.2021 Original published format: US 202163165938 P | US202263306377P | 03.02.2022 Original published format: US 202263306377 P | [2024/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022204399 | Date: | 29.09.2022 | Language: | EN | [2022/39] | Type: | A1 Application with search report | No.: | EP4313037 | Date: | 07.02.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.09.2022 takes the place of the publication of the European patent application. | [2024/06] | Search report(s) | International search report - published on: | US | 29.09.2022 | Classification | IPC: | A61K31/422, A61K9/00, A61K9/16 | [2024/06] | CPC: |
A61K31/422 (EP,IL,KR,US);
A61K9/2086 (US);
A61K47/34 (KR);
A61K9/0065 (KR);
A61K9/167 (EP,IL);
A61K9/2077 (EP,IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/06] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT ZOLMITRIPTAN | [2024/06] | English: | PHARMACEUTICAL COMPOSITIONS COMPRISING ZOLMITRIPTAN | [2024/06] | French: | COMPOSITIONS PHARMACEUTIQUES COMPRENANT DU ZOLMITRIPTAN | [2024/06] | Entry into regional phase | 04.10.2023 | National basic fee paid | 04.10.2023 | Search fee paid | 04.10.2023 | Designation fee(s) paid | 04.10.2023 | Examination fee paid | Examination procedure | 04.10.2023 | Examination requested [2024/06] | 03.05.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 03.01.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2016346200 (SOMMER ANDREAS [US], et al); | [XY]US2018028499 (BARABAN SCOTT C [US]); | [Y]US2020129502 (BOSSE PAUL [US], et al); | [PX]WO2021081376 (MAPLIGHT THERAPEUTICS INC [US]) |